4 Einträge gefunden

1. Cetuximab enhances the efficacy of bortezomib in squamous cell carcinoma cell lines.

   1. Wagenblast, Jens
   2. Baghi, Mehran
   3. Arnoldner, Christoph
   4. Bisdas, Sotirios
   5. Gstöttner, Wolfgang
   6. Ackermann, Hanns
   7. May, Angelika

   2009 - Forschungsinformationssystem des UKE
2. Antiproliferative activity of bortezomib alone and in combination with cisplatin or docetaxel in head and neck squamous cell carcinoma cell lines.

   1. Wagenblast, Jens
   2. Hambek, Markus
   3. Baghi, Mehran
   4. Gstöttner, Wolfgang
   5. Strebhardt, Klaus
   6. Ackermann, Hanns
   7. Knecht, Rainald

   2008 - Forschungsinformationssystem des UKE
3. Effects of combination treatment of bortezomib and dexamethasone in SCCHN cell lines depend on tumor cell specificity.

   1. Wagenblast, Jens
   2. Baghi, Mehran
   3. Arnoldner, Christoph
   4. Bisdas, Sotirios
   5. Gstöttner, Wolfgang
   6. May, Angelika
   7. Knecht, Rainald

   2008 - Forschungsinformationssystem des UKE
4. Effect of bortezomib and cetuximab in EGF-stimulated HNSCC.

   1. Wagenblast, Jens
   2. Baghi, Mehran
   3. Arnoldner, Christoph
   4. Bisdas, Sotirios
   5. Gstöttner, Wolfgang
   6. Ackermann, Hanns
   7. May, Angelika

   2008 - Forschungsinformationssystem des UKE